These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30077410)

  • 1. Comparison of [
    Li J; Dong J; Yang L; Li X; Song T
    Ultrasound Med Biol; 2018 Nov; 44(11):2199-2208. PubMed ID: 30077410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of vitality of liver lesions by alveolar echinococcosis. Comparison of parametric contrast enhanced ultrasound (SonoVue®) with quantified 18F-FDG-PET-CT.
    Kaltenbach TE; Graeter T; Mason RA; Kratzer W; Oeztuerk S; Haenle MM; Gruener B; Gottstein M
    Nuklearmedizin; 2015; 54(1):43-9. PubMed ID: 25423884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of disease activity in alveolar echinococcosis: a comparison of contrast enhanced ultrasound, three-phase helical CT and [(18)F] fluorodeoxyglucose positron emission tomography.
    Ehrhardt AR; Reuter S; Buck AK; Haenle MM; Mason RA; Gabelmann A; Kern P; Kratzer W
    Abdom Imaging; 2007 Nov; 32(6):730-6. PubMed ID: 17285403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion-Weighted MRI for the Initial Viability Evaluation of Parasites in Hepatic Alveolar Echinococcosis: Comparison with Positron Emission Tomography.
    Zheng J; Wang J; Zhao J; Meng X
    Korean J Radiol; 2018; 19(1):40-46. PubMed ID: 29353998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical value of the semi-quantitative parameters of
    Shen Z; Wang Y; Chen X; Chou S; Wang G; Wang Y; Xu X; Liu J; Wang R
    BMC Med Imaging; 2024 Jul; 24(1):194. PubMed ID: 39085759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alveolar echinococcosis: correlation between hepatic MRI findings and FDG-PET/CT metabolic activity.
    Azizi A; Blagosklonov O; Lounis A; Berthet L; Vuitton DA; Bresson-Hadni S; Delabrousse E
    Abdom Imaging; 2015 Jan; 40(1):56-63. PubMed ID: 24970734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. F-18-fluorodeoxyglucose (FDG) positron-emission tomography of Echinococcus multilocularis liver lesions: prospective evaluation of its value for diagnosis and follow-up during benzimidazole therapy.
    Stumpe KD; Renner-Schneiter EC; Kuenzle AK; Grimm F; Kadry Z; Clavien PA; Deplazes P; von Schulthess GK; Muellhaupt B; Ammann RW; Renner EL
    Infection; 2007 Feb; 35(1):11-8. PubMed ID: 17297583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficiency of liposomal albendazole for the treatment of the patients with complex alveolar echinococcosis: a comparative analysis of CEUS, CT, and PET/CT.
    Li H; Song T; Qin Y; Liu W; Li X; Shao Y; Wen H
    Parasitol Res; 2015 Nov; 114(11):4175-80. PubMed ID: 26239800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in ultrasound in the diagnosis and evaluation of the activity of hepatic alveolar echinococcosis.
    Yangdan CR; Wang C; Zhang LQ; Ren B; Fan HN; Lu MD
    Parasitol Res; 2021 Sep; 120(9):3077-3082. PubMed ID: 34370071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
    Jadvar H; Henderson RW; Conti PS
    J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic alveolar echinococcosis: correlation between computed tomography morphology and inflammatory activity in positron emission tomography.
    Graeter T; Eberhardt N; Shi R; Schmidberger J; Beer AJ; Beer M; Henne-Bruns D; Hillenbrand A; Barth TFE; Grimm J; Kratzer W; Gruener B
    Sci Rep; 2020 Jul; 10(1):11808. PubMed ID: 32678174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative evaluation of range and metabolic activity of hepatic alveolar echinococcosis lesion microenvironment using PET/CT and multi-site sampling method.
    Aini A; Yimingjiang M; Yasen A; Ran B; Jiang T; Li X; Wang J; Abulizi A; Li Z; Shao Y; Aji T; Wen H
    BMC Infect Dis; 2021 Jul; 21(1):702. PubMed ID: 34301188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of contrast-enhanced ultrasound (CEUS) for the diagnostic evaluation of hepatic echinococcosis.
    Schwarze V; Mueller-Peltzer K; Negrão de Figueiredo G; Lindner F; Rübenthaler J; Clevert DA
    Clin Hemorheol Microcirc; 2018; 70(4):449-455. PubMed ID: 30347607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovation in hepatic alveolar echinococcosis imaging: best use of old tools, and necessary evaluation of new ones.
    Liu W; Delabrousse É; Blagosklonov O; Wang J; Zeng H; Jiang Y; Wang J; Qin Y; Vuitton DA; Wen H
    Parasite; 2014; 21():74. PubMed ID: 25531446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of delayed 18F-FDG PET imaging in the follow-up of patients with alveolar echinococcosis.
    Caoduro C; Porot C; Vuitton DA; Bresson-Hadni S; Grenouillet F; Richou C; Boulahdour H; Blagosklonov O
    J Nucl Med; 2013 Mar; 54(3):358-63. PubMed ID: 23303963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
    Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
    Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of metabolic characteristics and viability of lipiodolized hepatocellular carcinomas using 18F-FDG PET/CT.
    Kim HO; Kim JS; Shin YM; Ryu JS; Lee YS; Lee SG
    J Nucl Med; 2010 Dec; 51(12):1849-56. PubMed ID: 21098794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-Enhanced Ultrasound in the Assessment of Patients with Indeterminate Abdominal Findings at Positron Emission Tomography Imaging.
    Catalano O; Sandomenico F; Vallone P; Setola SV; Granata V; Fusco R; Lastoria S; Mansi L; Petrillo A
    Ultrasound Med Biol; 2016 Nov; 42(11):2717-2723. PubMed ID: 27495384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.